Showing results (81-90 of 122) with videos related to
Sort By:
Pageof 13
BMC Public Health|March 31, 2010
Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?Tari J Turner, Hayley Barnes, Jane Reid, et al.Expert Review of Medical Devices|December 16, 2017
Designing medical technology for resilience: integrating health economics and human factors approachesSimone Borsci, Ijeoma Uchegbu, Peter Buckle, et al.Plos One|December 1, 2017
Usability study of pH strips for nasogastric tube placementSimone Borsci, Peter Buckle, Jeremy Huddy, et al.Work (Reading, Mass.)|August 30, 2008
Supermarket workers: their work and their health, particularly their self-reported musculoskeletal problems and compensable injuriesLina Forcier, Claire Lapointe, Monique Lortie, et al.Frontiers in Medical Technology|July 9, 2026
Reported best practices for effective risk management of medical devices: a scoping reviewRosario Luxardo, Arkeliana Tase, Florence Leong, et al.Palliative Medicine|June 14, 2025
End-of-life care experiences and long-term outcomes of bereaved neuro-oncology caregivers: A cross-sectional surveyShaista Meer, Peter Buckle, Rosanna Miller, et al.Frontiers in Digital Health|March 23, 2026
Integrating remote blood pressure monitoring into NHS primary care: a human factors perspectiveMassimo Micocci, Omar Butt, ShanShan Zhou, et al.Health Technology Assessment (Winchester, England)|August 4, 2025
Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trialPatrick Stone, Ollie Minton, Alison Richardson, et al.Journal of Clinical Epidemiology|October 14, 2019
Overviews of reviews incompletely report methods for handling overlapping, discordant, and problematic dataCarole Lunny, Sue E Brennan, Jane Reid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2024
Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled TrialPatrick Charles Stone, Ollie Minton, Alison Richardson, et al.Pageof 13